RxDoctor Payments Data

Morgan Gallo, DPM

Podiatrist · Erie, PANPI 1750908745

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,328 of the $7,779 with a category attached, or 81.3%. 25 manufacturers reported payments, led by Smith+Nephew at 48.5% of the total. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,779in general payments, 2019–2025

Across 137 payments — averaging $56.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • Organogenesis Inc.$871
  • Integra Lifesciences Corporation$450
  • Misonix Inc$362
  • Kerecis Limited$320
  • Medical Device Business Services, Inc.$260
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$1,17515%
  • Food & beverage$6,32881%
  • Education$2774%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,779 in reported general payments places this provider in the 90th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$167,985
Medicare patients
463
Services billed
2,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LyricaPregabalin11$9,818
Ammonium Lactate254$3,336
Ketoconazole111$2,200
Pregabalin43$2,161
Gabapentin110$1,910
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip23$1,008
Terbinafine Hcl66$387
Dexamethasone Sodium Phosphate21$377
Diclofenac Sodium13$351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$343
Ciclopirox22$338
Clotrimazole13$199
Methylprednisolone34$191
Cephalexin43$181
Mupirocin32$143

Paid to pharmacies, not to this prescriber.

Other podiatrist in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →